Exploring the Application of Narrative Medicine Combined With Case-Based Learning in the Standardized Training of General Practice Residents

Narrative Medicine Clinical Trial

Official title:

Narrative Medicine Combined With Case-Based Learning

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06436963
• Other study ID #: 2022KY815
• Status: Completed
• Phase: N/A
• Start date: July 1, 2022
• Est. completion date: December 31, 2023

Study information

• Verified date: May 2024
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. The experimental group received narrative medicine training combined with CBL training. The control group received normal CBL training. None of the participants had previously had any training in narrative medicine. Teaching evaluation scores were measured for all subjects at baseline and 1 year after the training.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 24 Years to 28 Years

Eligibility

Inclusion Criteria:

• first- and second-year general practice residents of Zhejiang University School of Medicine

Exclusion Criteria:

• third-year general practice residents of Zhejiang University School of Medicine

Related Conditions & MeSH terms

• Case-based Learning
• Narrative Medicine

Intervention

Behavioral:
• narrative medicine training combined with CBL training
The experimental group received narrative medicine training combined with CBL training.
• CBL training
The control group received normal CBL training.

Locations

Country	Name	City	State
China	Second Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Satisfaction Survey of Residents in the Experimental Group	The satisfaction survey was divided into five levels, ranging from "strongly agree" to "strongly disagree". The higher percent of agree means better result.	12 months
Primary	Comparison of the SEGUE scale scores Between the Experimental Group and the Control Group	The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.	12 months
Primary	Comparison of the JSE-S scale scores Between the Experimental Group and the Control Group	The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.	12 months
Primary	Comparison of the SEGUE scale in Different Grades Before and After Training in the Experimental Group	The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.	12 months
Primary	Comparison of the JSE-S scale in Different Grades Before and After Training in the Experimental Group	The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.	12 months